Pfizer Inc.
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|
| Revenue | $50.01B | $48.30B | $48.42B | $48.37B |
| US | $21.99B | $20.33B | $20.45B | $23.12B |
| International | $28.02B | $27.96B | $27.97B | $25.25B |
| Cost of Revenue | $8.46B | $8.11B | $11.24B | — |
| Gross Profit | $41.55B | $40.18B | $37.18B | — |
| Gross Margin | 83.1% | 83.2% | 76.8% | — |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | $14.75B | $14.54B | $15.63B | — |
| Operating Income | $11.91B | $10.21B | $9.28B | — |
| Operating Margin | 23.8% | 21.1% | 19.2% | — |
| Interest Expense | $1.23B | $516.0M | — | — |
| Pretax Income | $10.67B | $9.69B | $9.28B | — |
| Income Tax Expense | $2.15B | $1.65B | $1.02B | — |
| Net Income | $8.64B | $8.10B | $8.14B | — |
| Net Margin | 17.3% | 16.8% | 16.8% | — |
| EPS (Basic) | $1.23 | $1.20 | $1.18 | — |
| EPS (Diluted) | $1.23 | $1.20 | $1.17 | — |
| Shares Outstanding (Basic) | 7.01B | 6.73B | 6.92B | — |
| Shares Outstanding (Diluted) | 7.05B | 6.75B | 6.94B | — |
| Dividends Per Share | — | — | — | — |